Oral cancer is a cancerous growth in the mouth, on the tongue, lips or gums. The most common type of oral cancer is squamous cell carcinoma.

A new study published in the Journal of the European Academy of Dermatology and Venereology found that methotrexate (MTX) has ...

I do not know how to put this gently or tastefully, so I will factually describe what happened last night in Milwaukee: A former president of the United States held a rally, during which he used a ...

The Food and Drug Administration (FDA) has expanded the approval of Jylamvo (methotrexate) to include the treatment of pediatric patients with acute lymphoblastic leukemia (ALL), as part of a ...

The FDA has expanded the approval for Jylamvo, an oral methotrexate solution, to include pediatric patients with acute lymphoblastic leukemia (ALL). Jylamvo was the first oral methotrexate solution ...

For the subset of patients receiving methotrexate, the age range was also 32-88 years and the median age was 55 years. Nineteen of the 43 received methotrexate over varying durations, and in 16 of ...

Oral and maxillofacial surgeons perform surgeries on the face, mouth and jaw. These professionals are dentists with at least four years of additional surgery training, so they can do everything ...

When dentists look inside your mouth, they’re not just looking for cavities. They’re looking for gum disease and oral cancers, as well as assessing the overall health of the millions of bacteria, ...

About 18,000 Americans are diagnosed with a new case of oropharyngeal cancer each year, with a UK head, neck and thyroid surgeon pointing the finger at oral sex. Oropharyngeal cancer is a type of ...

HPV is sexually transmitted. For oropharyngeal cancer, the main risk factor is the number of lifetime sexual partners, especially oral sex. Those with six or more lifetime oral-sex partners are 8.5 ...

Cyclophosphamide (Cytoxan) is another type of oral chemotherapy that’s included in a combined treatment regimen called CMF (cyclophosphamide, methotrexate, fluorouracil). However ...